Le Lézard
Classified in: Health
Subjects: NPT, TRI

Breakthrough bioelectronic medicine discovery made by decoding immune system's neural signals


MANHASSET, N.Y., May 7, 2018 /PRNewswire-USNewswire/ -- Northwell Health's Feinstein Institute for Medical Research Assistant Professor Theodoros P. Zanos, PhD, and his collaborators are the first to decode specific signals the nervous system uses to communicate immune status and inflammation to the brain. Identifying these neural signals and what they're communicating about the body's health is a major step forward for bioelectronic medicine as it provides insight into diagnostic and therapeutic targets, and device development. These findings were published today in Proceedings of the National Academy of Sciences (PNAS).

Feinstein Institute for Medical Research Assistant Professor Theodoros P. Zanos, PhD, and his collaborators are the first to decode specific signals the nervous system uses to communicate immune status and inflammation to the brain.

It was already known that the vagus nerve, a nerve in the neck, controls the release of molecules called cytokines, which promote inflammation in many disease conditions. However, up until now, it was unknown if each type of cytokine was sending its own specific information about inflammation and immunity to the brain. In Dr. Zanos' study, he successfully decoded the neural signaling of two cytokines ? IL-1? and TNF ? in the vagus nerve of mice and found that each cytokine triggered their own specific response signal. 

"These results show that it is possible to detect specific cytokine signaling from the body's receptors to the brain, through electrical signals in the vagus nerve," said Dr. Zanos, lead author of the PNAS paper. "We will now use the neural decoding methods from this study to identify the neural signaling of a variety of medical conditions in future bioelectronic medicine studies. This is a key step to provide insights to engineer cutting-edge diagnostic and therapeutic devices."   

Bioelectronic medicine is an emerging field of medicine which combines neuroscience, molecular biology and bioengineering to tap into the nervous system to treat disease and injury without the use of pharmaceuticals. Conditions identified as benefitting from bioelectronic medicine therapies include rheumatoid arthritis, Crohn's disease, diabetes, paralysis and lupus.

"Dr. Zanos' findings are a major discovery in the field of bioelectronic medicine," said Kevin J. Tracey, MD, president and CEO of the Feinstein Institute. "We have long known that the nervous system communicates with the body. We can now learn the language by which it communicates, which enables us to fine tune how we help the body heal itself."

About the Feinstein Institute 
The Feinstein Institute for Medical Research is the research arm of Northwell Health, the largest healthcare provider in New York. Home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities, the Feinstein Institute includes 4,000 researchers and staff who are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine ? a new field of science that has the potential to revolutionize medicine. For more information about how we empower imagination and pioneer discovery, visit FeinsteinInstitute.org.

Contact: Heather E. Ball Mayer
516-465-7917
[email protected] 

(PRNewsfoto/Northwell Health) (PRNewsfoto/Northwell Health)

SOURCE The Feinstein Institute for Medical Research


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: